Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-24T07:02:12.575Z Has data issue: false hasContentIssue false
  • English
  • Français

Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors

Published online by Cambridge University Press:  21 May 2015

Heather J. Adam ,
Vanessa G. Allen ,
Andrea Currie ,
Allison J. McGeer ,
Andrew E. Simor ,
Susan E. Richardson ,
Lisa Louie ,
Barbara Willey ,
Tim Rutledge  and
Jacques Lee
...Show all authors
Heather J. Adam
Affiliation:
Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ont.
Vanessa G. Allen
Affiliation:
Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ont.
Andrea Currie
Affiliation:
Departments of Infection Prevention and Control and Emergency Medicine, North York General Hospital, North York, Ont.
Allison J. McGeer
Affiliation:
Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ont. Departments of Emergency Medicine and Microbiology, Mount Sinai Hospital, Toronto, Ont.
Andrew E. Simor
Affiliation:
Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ont. Departments of Microbiology and Emergency Medicine, Sunnybrook Health Sciences Centre, Toronto, Ont.
Susan E. Richardson
Affiliation:
Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ont. Division of Microbiology, Department of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, Ont.
Lisa Louie
Affiliation:
Departments of Microbiology and Emergency Medicine, Sunnybrook Health Sciences Centre, Toronto, Ont.
Barbara Willey
Affiliation:
Departments of Emergency Medicine and Microbiology, Mount Sinai Hospital, Toronto, Ont.
Tim Rutledge
Affiliation:
Departments of Infection Prevention and Control and Emergency Medicine, North York General Hospital, North York, Ont.
Jacques Lee
Affiliation:
Departments of Microbiology and Emergency Medicine, Sunnybrook Health Sciences Centre, Toronto, Ont.
Ran D. Goldman
Affiliation:
Department of Emergency Medicine, Vancouver Children’s Hospital, Vancouver, BC
Andrea Somers
Affiliation:
Department of Emergency Medicine, University Health Network, Toronto, Ont.
Paul Ellis
Affiliation:
Department of Emergency Medicine, University Health Network, Toronto, Ont.
Alicia Sarabia
Affiliation:
Departments of Microbiology and Emergency Medicine, Credit Valley Hospital; Toronto, Ont.
John Rizos
Affiliation:
Departments of Microbiology and Emergency Medicine, Credit Valley Hospital; Toronto, Ont.
Bjug Borgundvaag
Affiliation:
Departments of Emergency Medicine and Microbiology, Mount Sinai Hospital, Toronto, Ont.
Kevin C. Katz*
Affiliation:
Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ont. Departments of Infection Prevention and Control and Emergency Medicine, North York General Hospital, North York, Ont. Department of Laboratory Medicine, North York General Hospital; North York, Ont.
*
Department of Laboratory Medicine, North York General Hospital, Toronto ON M2K 1E1; [email protected]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), which is caused primarily by the Canadian methicillin-resistant Staphylococcus aureus-10 (CMRSA-10) strain (also known as the USA300 strain) has emerged rapidly in the United States and is now emerging in Canada. We assessed the prevalence, risk factors, microbiological characteristics and outcomes of CA-MRSA in patients with purulent skin and soft tissue infections (SSTIs) presenting to emergency departments (EDs) in the Greater Toronto Area.

Methods:

Patients with Staphylococcus aureus SSTIs who presented to 7 EDs between Mar. 1 and Jun. 30, 2007, were eligible for inclusion in this study. Antimicrobial susceptibilities and molecular characteristics of MRSA strains were identified. Demographic, risk factor and clinical data were collected through telephone interviews.

Results:

MRSA was isolated from 58 (19%) of 299 eligible patients. CMRSA-10 was identified at 6 of the 7 study sites and accounted for 29 (50%) of all cases of MRSA. Telephone interviews were completed for 161 of the eligible patients. Individuals with CMRSA-10 were younger (median 34 v. 63 yr, p = 0.002), less likely to report recent antibiotic use (22% v. 67%, p = 0.046) or health care–related risk factors (33% v. 72%, p = 0.097) and more likely to report community-related risk factors (56% v. 6%, p = 0.008) than patients with other MRSA strains. CMRSA-10 SSTIs were treated with incision and drainage (1 patient), antibiotic therapy (3 patients) or both (5 patients), and all resolved. CMRSA-10 isolates were susceptible to clindamycin, tetracycline and trimethoprimsulfamethoxazole.

Conclusion:

CA-MRSA is a significant cause of SSTIs in the Greater Toronto Area, and can affect patients without known community-related risk factors. The changing epidemiology of CA-MRSA necessitates further surveillance to inform prevention strategies and empiric treatment guidelines.

Keywords

Staphylococcus aureusmethicillin resistancecommunity-associated infectionsrisk factorsskin diseases and infectionssoft tissue infectionspediatricfever
Type
Original Research • Recherche originale
Information
Canadian Journal of Emergency Medicine , Volume 11 , Issue 5 , September 2009 , pp. 439 - 446
Copyright
Copyright © Canadian Association of Emergency Physicians 2009

References

REFERENCES

1.Barton, M, Hawkes, M, Moore, D, et al Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA): a perspective for Canadian health care practitioners. Can J Infect Dis Med Micro 2006;17(Suppl C):1B–24B.Google Scholar
2.Gilbert, M, MacDonald, J, Gregson, D, et al Outbreak in alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 2006;175:149–54.Google Scholar
3.Groom, AV, Wolsey, DH, Naimi, TS, et al Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001; 286:1201–5.Google Scholar
4.Kaplan, SL, Hulten, K, Gonzalez, B, et al Three-year surveillance of community-acquired Staphylococus aureus infections in children. Clin Infect Dis 2005;40:1785–91. Google Scholar
5Kazakova, S, Hageman, J, Matava, M, et al A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468–75.Google Scholar
6.Lee, NE, Taylor, MM, Bancroft, E, et al Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005;40:1529–34.Google Scholar
7.Main, CL, Jayarante, P, Haley, A, et al Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can J Infect Dis Med Microbiol 2005;16:343–8.Google Scholar
8.Mathews, WC, Caperna, J, Barber, R, et al Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005;40:155–60.Google Scholar
9.Rosenthal, A, White, D, Churilla, S, et al Optimal surveillance culture sites for detection of methicillin-resistant Staphylococcus aureus in newborns. J Clin Microbiol 2006;44:4234–6.Google Scholar
10.Zinderman, CE, Conner, B, Malakooti, MA, et al Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 2004;10:941–4.Google Scholar
11.Ruhe, J, Smith, N, Menon, A, et al Significance of antibiotic therapy for the treatment of community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections. Interscience Conference on Antimicrobial Agents and Chemotherapy; 2006 September 27–30; San Francisco (CA): American Society for Microbiology.Google Scholar
12.Moran, GJ, Krishnadasan, A, Gorwitz, RJ, et al Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–74.Google Scholar
13.Weese, JS, Rousseau, J, Willey, B, et al Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Intern Med 2006;20:182–6.Google Scholar
14.Kurbis, C, Wylie, J. Community-based cluster of methicillin-resistant Staphylococcus aureus in Manitoba. Can J Infect Dis 2001;12:149–52.Google Scholar
15.McGeer, A, Fleming, C, Green, K, et al Antimicrobial resistance in common hospital pathogens in Ontario. QMPLS News 2007;116:1–12.Google Scholar
16.Surveillance for methicillin-resistant Staphylococcus aureus (MRSA) 2006 Results. Ottawa (ON): Canadian Nosocomial Infection Surveillance Program (CNISP); 2006. Available: www.phac-aspc.gc.ca/nois-sinp/projects/pdf/mrsa_report2006-eng.pdf (accessed 2009 July 28).Google Scholar
17.Naimi, TS, LeDell, KH, Como-Sabetti, K, et al Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976–84.Google Scholar
18.Labandeira-Rey, M, Couzon, F, Boisset, S, et al Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007;315:1130–3.Google Scholar
19.Popovich, K, Hota, B, Rice, T, et al Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007;45:2293–5.Google Scholar
20.Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 17th informational supplement. m100-s17. Wayne (PA): The Institute; 2007.Google Scholar
21.Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A7. Wayne (PA): The Institute; 2006.Google Scholar
22.Fuchs, PC, Jones, RN, Barry, AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990;28:608–9.Google Scholar
23.Toma, E, Barriault, D. Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci. J Clin Microbiol 1995;33:1712–5.Google Scholar
24.Mulvey, MR, Chui, L, Ismail, J, et al Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol 2001;39:3481–5.Google Scholar
25.Lina, G, Piemont, Y, Godail-Gamot, F, et al Involvement of panton-valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128–32.Google Scholar
26.Oliveira, DC, de Lencastre, H. Multiplex PCR strategy for rapid identification of structural types and variants of the MEC element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:2155–61.Google Scholar
27.Willey, B, Wong, H, Louie, L, et al Editors. Comparison of two strategies for staphylococcal cassette chromosome mec (sccmec) typing in methicillin-resistant Staphylococcus aureus. San Francisco, (CA): 46th Interscience Conference on Antimi-crobial Agents and Chemotherapy; 2006 September 27-30.Google Scholar
28.Seybold, U, Kourbatova, EV, Johnson, JG, et al Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647–56.Google Scholar
29.Lee, MC, Rios, AM, Aten, MF, et al Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123–7.Google Scholar
30.Rajendran, PM, Young, D, Maurer, T, et al Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007;51:4044–8.Google Scholar
31.Diep, BA, Chambers, HF, Graber, CJ, et al Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008;148:249–57.Google Scholar
32.Talan, DA, Moran, GJ, Mower, WR, et al Emergency ID net: an emergency department-based emerging infections sentinel network. The emergency ID net study group. Ann Emerg Med 1998;32:703–11.Google Scholar
33.Mulvey, MR, MacDougall, L, Cholin, B, et al Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 2005;11:844–50.Google Scholar